Viewing Study NCT05394168


Ignite Creation Date: 2025-12-24 @ 5:49 PM
Ignite Modification Date: 2025-12-27 @ 1:43 AM
Study NCT ID: NCT05394168
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-04-01
First Post: 2022-04-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I Clinical Study of HLX53 in Advanced/Metastatic Solid Tumors
Sponsor: Shanghai Henlius Biotech
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module